Responses of aldosterone-producing adenomas to ACTH and angiotensins. 1979

T Saruta, and T Okuno, and T Eguchi, and R Nakamura, and I Saito, and K Kondo, and M Oka, and S Matsuki

To elucidate the control mechanism of aldosterone production in primary aldosteronism, in vivo and in vitro studies were done in 7 patients with aldosterone-producing adenomas. In the in vivo study, plasma aldosterone was stimulated more significantly by (Formula: see text), synthetic ACTH than by angiotensin II or furosemide. Diurnal variations of plasma aldosterone, which were studied in 4 patients, were similar to those seen in normal controls. In agreement with the results in the in vivo study, the in vitro study also revealed ACTH stimulated aldosterone and deoxycorticosterone (DOC) from the adenoma more markedly than angiotensin II or III. There was no adenoma which was more sensitivie to angiotenion II or III than to ACTH. From these results it is considered that changes in plasma aldosterone induced by the exogenous administration of angiotensin II or ACTH in patients with aldosterone-producing adenoma are mainly based on changes in aldosterone production in the adenoma. Furthermore, in patients with an aldosterone-producing adenoma in whom diurnal variations of plasma aldosterone similar to those in normal subjects are observed, responses of aldosterone to angiotensin II are supposed to be less than those to ACTH.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D003900 Desoxycorticosterone A steroid metabolite that is the 11-deoxy derivative of CORTICOSTERONE and the 21-hydroxy derivative of PROGESTERONE 21-Hydroxyprogesterone,Cortexone,Deoxycorticosterone,Desoxycortone,11-Decorticosterone,21-Hydroxy-4-pregnene-3,20-dione,11 Decorticosterone,21 Hydroxy 4 pregnene 3,20 dione,21 Hydroxyprogesterone
D005260 Female Females
D005665 Furosemide A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. Frusemide,Fursemide,Errolon,Frusemid,Furanthril,Furantral,Furosemide Monohydrochloride,Furosemide Monosodium Salt,Fusid,Lasix
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006929 Hyperaldosteronism A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA. Aldosteronism,Conn Syndrome,Conn's Syndrome,Primary Hyperaldosteronism,Conns Syndrome,Hyperaldosteronism, Primary,Syndrome, Conn,Syndrome, Conn's
D000236 Adenoma A benign epithelial tumor with a glandular organization. Adenoma, Basal Cell,Adenoma, Follicular,Adenoma, Microcystic,Adenoma, Monomorphic,Adenoma, Papillary,Adenoma, Trabecular,Adenomas,Adenomas, Basal Cell,Adenomas, Follicular,Adenomas, Microcystic,Adenomas, Monomorphic,Adenomas, Papillary,Adenomas, Trabecular,Basal Cell Adenoma,Basal Cell Adenomas,Follicular Adenoma,Follicular Adenomas,Microcystic Adenoma,Microcystic Adenomas,Monomorphic Adenoma,Monomorphic Adenomas,Papillary Adenoma,Papillary Adenomas,Trabecular Adenoma,Trabecular Adenomas
D000310 Adrenal Gland Neoplasms Tumors or cancer of the ADRENAL GLANDS. Adrenal Cancer,Adrenal Gland Cancer,Adrenal Neoplasm,Cancer of the Adrenal Gland,Neoplasms, Adrenal Gland,Adrenal Cancers,Adrenal Gland Cancers,Adrenal Gland Neoplasm,Adrenal Neoplasms,Cancer, Adrenal,Cancer, Adrenal Gland,Cancers, Adrenal,Cancers, Adrenal Gland,Neoplasm, Adrenal,Neoplasm, Adrenal Gland,Neoplasms, Adrenal

Related Publications

T Saruta, and T Okuno, and T Eguchi, and R Nakamura, and I Saito, and K Kondo, and M Oka, and S Matsuki
August 1984, The Journal of laboratory and clinical medicine,
T Saruta, and T Okuno, and T Eguchi, and R Nakamura, and I Saito, and K Kondo, and M Oka, and S Matsuki
January 2019, Vitamins and hormones,
T Saruta, and T Okuno, and T Eguchi, and R Nakamura, and I Saito, and K Kondo, and M Oka, and S Matsuki
February 2008, Kidney international,
T Saruta, and T Okuno, and T Eguchi, and R Nakamura, and I Saito, and K Kondo, and M Oka, and S Matsuki
July 2017, Hypertension (Dallas, Tex. : 1979),
T Saruta, and T Okuno, and T Eguchi, and R Nakamura, and I Saito, and K Kondo, and M Oka, and S Matsuki
July 1999, Annals of internal medicine,
T Saruta, and T Okuno, and T Eguchi, and R Nakamura, and I Saito, and K Kondo, and M Oka, and S Matsuki
July 2007, Kidney international,
T Saruta, and T Okuno, and T Eguchi, and R Nakamura, and I Saito, and K Kondo, and M Oka, and S Matsuki
April 2000, Annals of internal medicine,
T Saruta, and T Okuno, and T Eguchi, and R Nakamura, and I Saito, and K Kondo, and M Oka, and S Matsuki
April 2000, Annals of internal medicine,
T Saruta, and T Okuno, and T Eguchi, and R Nakamura, and I Saito, and K Kondo, and M Oka, and S Matsuki
February 2020, Hypertension (Dallas, Tex. : 1979),
T Saruta, and T Okuno, and T Eguchi, and R Nakamura, and I Saito, and K Kondo, and M Oka, and S Matsuki
May 1993, Clinical and experimental pharmacology & physiology,
Copied contents to your clipboard!